Literature DB >> 1992328

Gynecomastia during omeprazole therapy.

L Santucci, F Farroni, S Fiorucci, A Morelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1992328     DOI： 10.1056/NEJM199102283240917

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

2.  Endocrine adverse effects of omeprazole.

Authors:  M Lindquist; I R Edwards
Journal:  BMJ       Date:  1992-08-22

3.  Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System.

Authors:  Alfonso Carvajal; Diego Macias; Angélica Gutiérrez; Sara Ortega; María Sáinz; Luis H Martín Arias; Alfonso Velasco
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  BMJ       Date:  1994-02-19

Review 5.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 6.  A comparative overview of the adverse effects of antiulcer drugs.

Authors:  D W Piper
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

7.  Transmucosal gastric leak induced by proton pump inhibitors.

Authors:  Lisa J Murray; Melissa Gabello; David S Rudolph; Christopher P Farrell; Melissa Morgan; Aaron P Martin; James C Underwood; M Carmen Valenzano; James M Mullin
Journal:  Dig Dis Sci       Date:  2008-11-18       Impact factor: 3.199

Review 8.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 9.  Gynecomastia and drugs: a critical evaluation of the literature.

Authors:  Frank Q Nuttall; Rohit S Warrier; Mary C Gannon
Journal:  Eur J Clin Pharmacol       Date:  2015-04-02       Impact factor: 2.953

10.  Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real-world evidence study.

Authors:  Jui-Ming Liu; Chun-Te Wu; Ren-Jun Hsu; Wen-Lin Hsu
Journal:  Cancer Med       Date:  2021-09-29       Impact factor: 4.452
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.